Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria.
暂无分享,去创建一个
T. Zuberbier | G. Canonica | F. Simons | C. Bindslev‐Jensen | P. Schmid‐Grendelmeier | W. Aberer | G. Vena | M. Gonçalo | M. Sanchez‐Borges | Z. Brzoza | A. Nast | A. Kaplan | A. Gimenez-Arnau | P. Staubach | B. Wedi | M. Maurer | M. Church | M. Hide | P. Mathelier-Fusade | R. Asero | A. Kapp | M. Metz | K. Godse | L. Ensina | S. Saini | C. Grattan | E. Toubi | A. H. Abdul Latiff | G. Sussman | J. Hebert | X. Zhu | A. Giménez-Arnau | X. Zhu | X. Zhu | X. Zhu | A. A. Abdul Latiff
[1] C. Baliu-Piqué,et al. Three cases of solar urticaria successfully treated with omalizumab , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.
[2] T. Jakob,et al. Failure of omalizumab in the treatment of solar urticaria , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.
[3] I. Momas,et al. Occupational contact urticaria: lessons from the French National Network for Occupational Disease Vigilance and Prevention (RNV3P) , 2015, The British journal of dermatology.
[4] M. Magerl,et al. An improved Peltier effect‐based instrument for critical temperature threshold measurement in cold‐ and heat‐induced urticaria , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[5] R. Swerlick,et al. Delayed pressure urticaria: response to treatment with sulfasalazine in a case series of seventeen patients , 2015, Dermatologic therapy.
[6] A. Tanoğlu,et al. Healing Effects of Omalizumab in a Patient with Cholinergic Urticaria Associated Severe Dyspeptic Complaints , 2015, Chinese Medical Journal.
[7] M. Magerl,et al. Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism , 2015, Clinical and experimental dermatology.
[8] M. Maurer,et al. Successful treatment of cholinergic urticaria with methantheliniumbromide , 2015, The Journal of dermatology.
[9] A. Giménez-Arnau,et al. Temperature thresholds in assessment of the clinical course of acquired cold contact urticaria: a prospective observational one-year study. , 2015, Acta dermato-venereologica.
[10] Stefan L. Montgomery. Cholinergic Urticaria and Exercise-Induced Anaphylaxis , 2015, Current sports medicine reports.
[11] R. Porcher,et al. Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study. , 2014, Journal of the American Academy of Dermatology.
[12] M. Maurer,et al. Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. , 2014, Journal of dermatological science.
[13] T. Zuberbier,et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.
[14] S. Kim,et al. Clinical Characteristics of Cholinergic Urticaria in Korea , 2014, Annals of dermatology.
[15] P. Martus,et al. German version of ItchyQoL: validation and initial clinical findings. , 2013, Acta dermato-venereologica.
[16] D. Staumont-Sallé,et al. Effective treatment of idiopathic chronic cold urticaria with omalizumab: report of 3 cases. , 2013, Journal of the American Academy of Dermatology.
[17] M. Ben-Shoshan,et al. Cold-induced urticaria: challenges in diagnosis and management , 2013, BMJ Case Reports.
[18] M. Maurer,et al. Omalizumab for chronic urticaria. , 2013, The New England journal of medicine.
[19] Matthew C. Altman,et al. Omalizumab for chronic urticaria. , 2013, The New England journal of medicine.
[20] T. Zuberbier,et al. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria , 2013, Allergy.
[21] M. Grahovac,et al. Solar urticaria: long‐term rush hardening by inhibition spectrum narrow‐band UVB 311nm , 2013, Clinical and experimental dermatology.
[22] M. Maurer,et al. Practical algorithm for diagnosing patients with recurrent wheals or angioedema , 2013, Allergy.
[23] A. Sheraz,et al. Cholinergic urticaria responding to botulinum toxin injection for axillary hyperhidrosis , 2013, The British journal of dermatology.
[24] H. Maibach,et al. Immunologic contact urticaria – the human touch , 2013, Cutaneous and ocular toxicology.
[25] T. Zuberbier,et al. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study. , 2013, Acta dermato-venereologica.
[26] T. Casale,et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. , 2013, The New England journal of medicine.
[27] A. Pressler,et al. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio‐oedema , 2013, Clinical and experimental dermatology.
[28] T. Zuberbier,et al. Management of chronic spontaneous urticaria in real life – in accordance with the guidelines? A cross‐sectional physician‐based survey study , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.
[29] H. Maibach,et al. Reactions of non‐immunologic contact urticaria on scalp, face, and back , 2012, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.
[30] P. Martus,et al. Development and construct validation of the angioedema quality of life questionnaire , 2012, Allergy.
[31] P. Schmid‐Grendelmeier,et al. Treatment of Severe Cold Contact Urticaria with Omalizumab: Case Reports , 2012, Case Reports in Dermatology.
[32] G. Canonica,et al. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity. , 2012, Acta dermato-venereologica.
[33] C. Nishigori,et al. Successful and long‐lasting treatment of solar urticaria with ultraviolet A rush hardening therapy , 2012, The British journal of dermatology.
[34] P. Martus,et al. Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H1‐antihistamine dose escalation , 2012, The British journal of dermatology.
[35] E. Kocaturk,et al. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey , 2012, The Journal of dermatology.
[36] O. Kalayci,et al. Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria , 2012, Archives of Dermatological Research.
[37] Z. Fedorowicz,et al. Histamine H2-receptor antagonists for urticaria. , 2012, The Cochrane database of systematic reviews.
[38] C. Bindslev‐Jensen,et al. Cold Urticaria Patients Exhibit Normal Skin Levels of Functional Mast Cells and Histamine after Tolerance Induction , 2012, Dermatology.
[39] H. Wedner,et al. Factors that predict the success of cyclosporine treatment for chronic urticaria. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[40] D. Yoo,et al. Aquagenic Urticaria: A Report of Two Cases , 2011, Annals of dermatology.
[41] T. Luger,et al. Delayed pressure urticaria – Dapsone heading for first‐line therapy? , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[42] M. Košnik,et al. Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria. , 2011, Respiratory medicine.
[43] K. Kulthanan,et al. Physical urticaria: prevalence, type and natural course in a tropical country , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.
[44] S. Spector,et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. , 2011, The Journal of allergy and clinical immunology.
[45] K. Brockow,et al. H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study , 2011, PloS one.
[46] F. Cambazard,et al. Solar urticaria treated with intravenous immunoglobulins. , 2011, Journal of the American Academy of Dermatology.
[47] K. Schäkel,et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. , 2011, The Journal of allergy and clinical immunology.
[48] J. Bousquet,et al. Recommendations for assessing patient‐reported outcomes and health‐related quality of life in patients with urticaria: a GA2LEN taskforce position paper , 2011, Allergy.
[49] A. Kaplan,et al. Omalizumab is effective in nonautoimmune urticaria. , 2011, The Journal of allergy and clinical immunology.
[50] T. Zuberbier,et al. Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL). , 2011, Journal of dermatological science.
[51] M. Llamas-Velasco,et al. Solar urticaria unresponsive to intravenous immunoglobulins , 2011, Photodermatology, photoimmunology & photomedicine.
[52] T. Zuberbier,et al. Antihistamine‐resistant urticaria factitia successfully treated with anti‐immunoglobulin E therapy , 2010, Allergy.
[53] Holger J Schünemann,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. , 2010, The Journal of allergy and clinical immunology.
[54] H. Maibach,et al. Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story". , 2010, European journal of dermatology : EJD.
[55] T. Zuberbier,et al. Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria , 2010, International Archives of Allergy and Immunology.
[56] T. Zuberbier,et al. Modern Approaches to the Diagnosis and Treatment of Cold Contact Urticaria , 2010, Current allergy and asthma reports.
[57] J. Bousquet,et al. Risk of first‐generation H1‐antihistamines: a GA2LEN position paper , 2010, Allergy.
[58] T. Zuberbier,et al. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study , 2010, Allergy.
[59] Todor A Popov,et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. , 2010, The Journal of allergy and clinical immunology.
[60] T. Zuberbier,et al. Effects of a pseudoallergen‐free diet on chronic spontaneous urticaria: a prospective trial , 2010, Allergy.
[61] C. Bindslev‐Jensen,et al. Efficacy of omalizumab in delayed pressure urticaria: a case report , 2010, Allergy.
[62] G. Murphy,et al. Solar urticaria successfully treated with intravenous immunoglobulin , 2009, Clinical and experimental dermatology.
[63] M. Maurer,et al. The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA2LEN/EDF/UNEV consensus panel recommendations , 2009, Allergy.
[64] B. Wedi,et al. Effective treatment of refractory severe heat urticaria with omalizumab , 2009, Allergy.
[65] H. Schünemann,et al. EAACI/GA²LEN/EDF/WAO guideline: management of urticaria , 2009, Allergy.
[66] M. Maurer,et al. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mg , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[67] T. Luger,et al. [Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series]. , 2009, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[68] T. Zuberbier,et al. Prevention of signs and symptoms of dermographic urticaria by single‐dose ebastine 20 mg , 2009, Clinical and experimental dermatology.
[69] G. Hudes,et al. The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[70] T. Zuberbier,et al. The German version of the chronic urticaria quality‐of‐life questionnaire: factor analysis, validation, and initial clinical findings , 2009, Allergy.
[71] M. Maurer,et al. Antipruritische Wirksamkeit einer hoch dosierten Antihistaminikatherapie , 2009, Der Hautarzt.
[72] P. Auquier,et al. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life , 2009, Allergy.
[73] T. Zuberbier,et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. , 2009, The Journal of allergy and clinical immunology.
[74] David M Lang,et al. Utility of routine laboratory testing in management of chronic urticaria/angioedema. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[75] G. Di Fede,et al. Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review , 2008, Journal of asthma and allergy.
[76] P. Filipe,et al. Solar urticaria treated successfully with intravenous high‐dose immunoglobulin: a case report , 2008, Photodermatology, photoimmunology & photomedicine.
[77] G. Konstantinou,et al. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. , 2008, Journal of the American Academy of Dermatology.
[78] R. Zeldin,et al. Treatment of chronic autoimmune urticaria with omalizumab. , 2008, The Journal of allergy and clinical immunology.
[79] T. Zuberbier,et al. How to assess disease activity in patients with chronic urticaria? , 2008, Allergy.
[80] S. Ozturk,et al. Low‐dose and short‐term cyclosporine treatment in patients with chronic idiopathic urticaria: A clinical and immunological evaluation , 2008, The Journal of dermatology.
[81] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[82] B. Engin,et al. Prospective randomized non‐blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.
[83] F. Bechara,et al. Localized heat urticaria in a child , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.
[84] T. Zuberbier,et al. Successful treatment of solar urticaria with anti‐immunoglobulin E therapy , 2008, Allergy.
[85] J. H. Feinberg,et al. Successful treatment of disabling cholinergic urticaria. , 2008, Military medicine.
[86] T. Zuberbier,et al. Successful treatment of cholinergic urticaria with anti‐immunoglobulin E therapy , 2008, Allergy.
[87] T. Zuberbier,et al. Acquired cold urticaria symptoms can be safely prevented by ebastine , 2007, Allergy.
[88] S. Schwartz,et al. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. , 2007, The Journal of allergy and clinical immunology.
[89] M. Sticherling,et al. Cold urticaria: tolerance induction with cold baths , 2007, The British journal of dermatology.
[90] L. Dubertret,et al. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. , 2007, European journal of dermatology : EJD.
[91] E. Arnáiz,et al. Rupatadine in the treatment of chronic idiopathic urticaria: a double‐blind, randomized, placebo‐controlled multicentre study , 2007, Allergy.
[92] T. Zuberbier,et al. Acquired cold urticaria: clinical picture and update on diagnosis and treatment , 2007, Clinical and experimental dermatology.
[93] T. Zuberbier,et al. Urticaria: current opinions about etiology, diagnosis and therapy. , 2007, Acta dermato-venereologica.
[94] R. Asero. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above‐licensed doses , 2006, Clinical and experimental dermatology.
[95] G. Vena,et al. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. , 2006, Journal of the American Academy of Dermatology.
[96] Ronald W. England,et al. Severe refractory cholinergic urticaria treated with danazol. , 2006, Journal of drugs in dermatology : JDD.
[97] J. Boyce. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. , 2006, The Journal of allergy and clinical immunology.
[98] H. Shimizu,et al. Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines , 2006, Clinical and experimental dermatology.
[99] W. Pichler,et al. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled, parallel, multicenter study , 2006, International journal of dermatology.
[100] H. Schünemann,et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.
[101] T. Zuberbier,et al. EAACI/GA2LEN/EDF guideline: management of urticaria , 2006, Allergy.
[102] T. Zuberbier,et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.
[103] J. Sánchez-Carazo,et al. Familial Aquagenic Urticaria and Bernard-Soulier Syndrome , 2005, Dermatology.
[104] A. Katsarou-Katsari,et al. Theophylline as “Add-on” Therapy in Patients with Delayed Pressure Urticaria: A Prospective Self-Controlled Study , 2005, International journal of immunopathology and pharmacology.
[105] A. Baptist,et al. Aquagenic urticaria with extracutaneous manifestations. , 2005, Allergy and Asthma Proceedings.
[106] M. Maurer,et al. Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. , 2004, The Journal of allergy and clinical immunology.
[107] E. Nettis,et al. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double‐blind, placebo‐controlled study , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[108] N. Martinelli,et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. , 2004, The Journal of allergy and clinical immunology.
[109] A. Black,et al. Delayed pressure urticaria. , 2004, Immunology and allergy clinics of North America.
[110] W. Chong,et al. Solar urticaria in Singapore: an uncommon photodermatosis seen in a tertiary dermatology center over a 10‐year period , 2004, Photodermatology, photoimmunology & photomedicine.
[111] S. Dogra,et al. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria , 2004, The Journal of dermatological treatment.
[112] J. Bazex,et al. Localized aquagenic urticaria: efficacy of a barrier cream , 2003, Contact dermatitis.
[113] E. Nettis,et al. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria. , 2003, The Journal of allergy and clinical immunology.
[114] W. Pichler,et al. Zafirlukast has no beneficial effects in the treatment of chronic urticaria , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[115] Z. Erbagci. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. , 2002, The Journal of allergy and clinical immunology.
[116] W. Pichler,et al. Chronisch idiopathische Urtikaria: Wirksamkeit von Fexofenadin , 2002 .
[117] Y. Koh,et al. Localized heat urticaria associated with mast cell and eosinophil degranulation. , 2002, The Journal of allergy and clinical immunology.
[118] T. Zuberbier,et al. Definition, classification, and routine diagnosis of urticaria: a consensus report. , 2001, The journal of investigative dermatology. Symposium proceedings.
[119] T. Zuberbier,et al. Management of urticaria: a consensus report. , 2001, The journal of investigative dermatology. Symposium proceedings.
[120] S. Leonardi,et al. Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[121] I. Tagarro,et al. Azelastine Tablets in the Treatment of Chronic Idiopathic Urticaria , 2001, Skin Pharmacology and Physiology.
[122] M. Kawashima,et al. Efficacy and Safety of Fexofenadine HCl in Japanese Patients with Chronic Idiopathic Urticaria , 2001, International Archives of Allergy and Immunology.
[123] J. Ring,et al. Once‐daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled study , 2001, International journal of dermatology.
[124] P. Seed,et al. Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticaria , 2000, The British journal of dermatology.
[125] A. Thompson,et al. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. , 2000, Journal of the American Academy of Dermatology.
[126] H. Nelson,et al. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[127] M. Murrieta,et al. Comparative therapeutic effect and safety of mizolastineand loratadine in chronic idiopathic urticaria , 2000 .
[128] P. Pigatto,et al. Chronic urticaria: a mystery , 2000, Allergy.
[129] Y. Berkun,et al. Successful treatment of delayed pressure urticaria with montelukast , 2000, Allergy.
[130] T. Horio,et al. The clinical and photobiological characteristics of solar urticaria in 40 patients , 2000, The British journal of dermatology.
[131] J. Zic,et al. Localized heat urticaria. , 1999, Journal of the American Academy of Dermatology.
[132] J. Ring,et al. Antihistamines in urticaria , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[133] L. Dubertret,et al. Efficacy and safety of mizolastine 10 mg in a placebo‐controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR study 1 , 1999, Journal of the European Academy of Dermatology and Venereology : JEADV.
[134] L. Nguyễn,et al. Aquagenic urticaria: report of a case and review of the literature. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[135] T. Zuberbier,et al. Differential effects of new‐generation H1‐receptor antagonists in pruritic dermatoses , 1998, Allergy.
[136] A. Kapp,et al. Physical urticaria: classification and diagnostic guidelines , 1997, Allergy.
[137] A. Kessel,et al. Low‐dose cyclosporin A in the treatment of severe chronic idiopathic urticaria , 1997, Allergy.
[138] A. Ros,et al. Cyclosporin A therapy for severe solar urticaria , 1997, Photodermatology, photoimmunology & photomedicine.
[139] T. Zuberbier,et al. Acute urticaria: clinical aspects and therapeutic responsiveness. , 1996, Acta dermato-venereologica.
[140] P. Blondin,et al. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria , 1996, Allergy.
[141] T. Zuberbier,et al. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. , 1995, Acta dermato-venereologica.
[142] E. Squire,et al. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[143] R. Barlow,et al. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. , 1993, Journal of the American Academy of Dermatology.
[144] S. Shuster,et al. The effect of cetirizine on symptoms and wealing in dermographic urticaria , 1993, The British journal of dermatology.
[145] G. Senna,et al. A comparison of the efficacy of Cetirizine and terfenadine , 1993, Allergy.
[146] J. Voorhees,et al. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. , 1991, Journal of the American Academy of Dermatology.
[147] C. Goh,et al. Cetirizine vs placebo in chronic idiopathic urticaria--a double blind randomised cross-over study. , 1991, Annals of the Academy of Medicine, Singapore.
[148] J. Ferguson,et al. A comparison of cetirizine and terfenadine in the management of solar urticaria. , 1991, Photodermatology, photoimmunology & photomedicine.
[149] P. Sarathchandra,et al. Contact urticaria due to the common stinging nettle (Urtica dioica)—histological, ultrastructural and pharmacological studies , 1991, Clinical and experimental dermatology.
[150] A. Alomar,et al. Cetirizine vs Astemizole in the Treatment of Chronic Idiopathic Urticaria , 1990, The Journal of international medical research.
[151] B. Czarnetzki. Ketotifen in cholinergic urticaria. , 1990, The Journal of allergy and clinical immunology.
[152] A. Wanderer. Essential acquired cold urticaria. , 1990, The Journal of allergy and clinical immunology.
[153] J. Berth-Jones,et al. Cholinergic pruritus, erythema and urticaria: a disease spectrum responding to danazol , 1989, The British journal of dermatology.
[154] A. Black,et al. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine , 1989, The British journal of dermatology.
[155] M. Greaves,et al. The effect of psoralen photochemotherapy (PUVA) on symptomatic dermographism , 1989, Clinical and experimental dermatology.
[156] A. Black,et al. Vibratory angioedema: lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy , 1989, The British journal of dermatology.
[157] C. Arendt,et al. Treatment of chronic urticaria with cetirizine dihydrochloride a non‐sedating antihistamine , 1988, The British journal of dermatology.
[158] E. Falk,et al. UVB treatment of factitious urticaria. , 1987, Photo-dermatology.
[159] M. Kaliner,et al. Delayed vibratory angioedema: insights into pathophysiologic mechanisms. , 1987, The Journal of allergy and clinical immunology.
[160] M. Greaves,et al. Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria , 1987, The British journal of dermatology.
[161] J. Warner,et al. ARTIFICIAL FOOD ADDITIVE INTOLERANCE IN PATIENTS WITH ANGIO-OEDEMA AND URTICARIA , 1986, The Lancet.
[162] H. Neittaanmäki. Cold urticaria. Clinical findings in 220 patients. , 1985, Journal of the American Academy of Dermatology.
[163] C. Genton,et al. Value of oral provocation tests to aspirin and food additives in the routine investigation of asthma and chronic urticaria. , 1985, The Journal of allergy and clinical immunology.
[164] M. Kaliner,et al. Mediator release in local heat urticaria: protection with combined H1 and H2 antagonists. , 1985, The Journal of allergy and clinical immunology.
[165] E. Pastorello,et al. Diagnosis of intolerance to food additives. , 1984, Annals of allergy.
[166] M. Greaves,et al. Symptomatic dermographism: Natural history, clinical features, laboratory investigations and response to therapy § , 1983, Clinical and experimental dermatology.
[167] G. Sussman,et al. Delayed pressure urticaria. , 1982, The Journal of allergy and clinical immunology.
[168] B. Kirchhof,et al. [Acetylsalicylic acid--additive intolerance phenomenon in chronic recurring urticaria]. , 1982, Dermatologische Monatschrift.
[169] B. Wüthrich,et al. [Acetylsalicylic acid and food additive intolerance in urticaria, bronchial asthma and rhinopathy]. , 1981, Schweizerische medizinische Wochenschrift.
[170] L. Juhlin. Recurrent urticaria: clinical investigation of 330 patients , 1981, The British journal of dermatology.
[171] H. Maibach,et al. Non-immunologic contact urticaria. , 1980, Acta dermato-venereologica. Supplementum.
[172] R. Clancy,et al. Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors , 1980, Clinical allergy.
[173] A. Black,et al. COLD URTICARIA TREATED BY INDUCTION OF TOLERANCE , 1979, The Lancet.
[174] A. Wanderer. An 'allergy' to cold. , 1979, Hospital Practice.
[175] C. Ramsay. Solar urticaria treatment by inducing tolerance to artificial radiation and natural light. , 1977, Archives of dermatology.
[176] G. Michaëlsson,et al. A follow‐up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates and azo dyes , 1976, The British journal of dermatology.
[177] R. F. Johnson. Letter: Incidence of dermographism. , 1976, British medical journal.
[178] R. Warin,et al. Challenge test battery in chronic urticaria , 1975, The British journal of dermatology.
[179] I. Leigh,et al. Localized heat urticaria treated by inducing tolerance to heat , 1975, The British journal of dermatology.
[180] Glatt Mm,et al. Letter: Scientific medicine. , 1974 .
[181] G. Michaëlsson,et al. Urticaria induced by preservatives and dye additives in food and drugs , 1973, The British journal of dermatology.
[182] L. Illig. [On the pathogenesis of cholinergic urticaria. I. Clinical observations and histological studies]. , 1967, Archiv fur klinische und experimentelle Dermatologie.
[183] F. Bettley. A device for the measurement of factitious urticaria. , 1962, The Journal of investigative dermatology.
[184] W. W. Duke. URTICARIA CAUSED SPECIFICALLY BY THE ACTION OF PHYSICAL AGENTS: (LIGHT, COLD, HEAT, FREEZING, BURNS, MECHANICAL IRRITATION, AND PHYSICAL AND MENTAL EXERTION) , 1924 .
[185] D. Weldon. Quality of life in patients with urticaria and angioedema: assessing burden of disease. , 2014, Allergy and asthma proceedings.
[186] A. Giménez-Arnau. Contact urticaria and the environment , 2014, Reviews on environmental health.
[187] K. Godse,et al. Prevalence of cholinergic urticaria in Indian adults , 2013, Indian dermatology online journal.
[188] B. Kalis. Double-Blind Multicentre Comparative Study of Ebastine, Terfenadine and Placebo in the Treatment of Chronic Idiopathic Urticaria in Adults , 2012, Drugs.
[189] T. Nagano,et al. Rapid desensitization with autologous sweat in cholinergic urticaria. , 2011, Allergology international : official journal of the Japanese Society of Allergology.
[190] A. Giménez-Arnau,et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[191] R. Asero,et al. Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. , 2010, Journal of investigational allergology & clinical immunology.
[192] J. Q. Rosso,et al. Experience with Cyclosporine in Children with Chronic Idiopathic Urticaria , 2010 .
[193] Carol Byrd-Bredbenner,et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. , 2010, The Journal of allergy and clinical immunology.
[194] U. Sahiner,et al. Aquagenic urticaria in 2 adolescents. , 2010, Journal of investigational allergology & clinical immunology.
[195] J. Bernstein,et al. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. , 2004, The Journal of allergy and clinical immunology.
[196] W. Pichler,et al. [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients]. , 2002, Praxis.
[197] M. Murrieta,et al. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group. , 2000, European journal of dermatology : EJD.
[198] D. Bakhos,et al. Clinical predictive factors of severity in cold urticaria. , 1998, Archives of dermatology.
[199] J. Frı́asa,et al. Treatment of aquagenic urticaria with PUVA and astemizole , 1997 .
[200] J. Sayag,et al. [Urticaria caused by cold. 104 cases]. , 1996, Annales de dermatologie et de venereologie.
[201] T. Zuberbier,et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. , 1996, Dermatology.
[202] L. Juhlin. Cetirizine in the treatment of chronic urticaria. , 1991, Clinical Therapeutics.
[203] J. Zayas,et al. Ebastine in chronic urticaria: A double-blind placebo-controlled study , 1991 .
[204] A. Lahti. Non-immunologic contact urticaria. Animal tests and their relevance. , 1988, Acta Dermato-Venereologica Supplementum.
[205] H. Degreef,et al. Pseudo-allergen-free diet in chronic urticaria. , 1983, Dermatologica.
[206] E. Rudzki,et al. Detection of urticaria with food additives intolerance by means of diet. , 1980, Dermatologica.
[207] L. Illig. [Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl)]. , 1979, Infection.
[208] P. Thune,et al. Provocation tests with antiphlogistica and food additives in recurrent urticaria. , 1975, Dermatologica.
[209] Leigh Im,et al. Cold urticaria-'desensitisation'. , 1974 .
[210] A. Heinicke,et al. [On the pathogenesis of cholinergic urticaria. 3. The influence of sweat secretion inhibition on cholinergic urticaria]. , 1967, Archiv fur klinische und experimentelle Dermatologie.
[211] Constitution of the World Health Organization. , 1946, American journal of public health and the nation's health.